Page last updated: 2024-10-25

eflornithine and Osteosarcoma

eflornithine has been researched along with Osteosarcoma in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Setty, BA1
Jin, Y1
Houghton, PJ1
Yeager, ND1
Gross, TG1
Nelin, LD1
Goto, H1
Matsui-Yuasa, I1
Otani, S1
Morisawa, S1
Nishizawa, Y1
Morii, H1

Other Studies

2 other studies available for eflornithine and Osteosarcoma

ArticleYear
Hypoxic Proliferation of Osteosarcoma Cells Depends on Arginase II.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 39, Issue:2

    Topics: Arginase; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Eflo

2016
Effects of parathyroid hormone on ornithine decarboxylase activity in human osteosarcoma cells.
    Archives of biochemistry and biophysics, 1991, May-01, Volume: 286, Issue:2

    Topics: Bucladesine; Butyrates; Butyric Acid; Cell Line; Cyclic AMP; DNA Replication; Eflornithine; Humans;

1991